Expert Commentary on Frequently Asked Questions in Ovarian Cancer

open access

Bradley Monk, MD, FACS, FACO 

Expert Commentary on Frequently Asked

Questions in Ovarian Cancer:

Unraveling the Risks and Benefits of Antiangiogenic

 Therapy for Ovarian Cancer Patients

  AXIS Medical Education

  A CME-certified grand rounds and webinar series  entitled, Unraveling the Risks   and Benefits of Antian-giogenic Therapy for Ovarian Cancer Patients, was held throughout the United States from October 2014 to April 2015. The questions asked by participants during these activities were collected, compiled, and categorized (see Figure 1 below). The questions high-light several areas of clinical focus in the treatment of ovarian cancer and will be addressed as part of this brief analysis......